Saal: Studio Terrasse 2.1
The United States is the undisputed world leader when it comes to medical biotechnology. Receiving FDA approval for a therapy is considered a milestone in a company's development and a blueprint for growth in other markets. Likewise, providers of innovative services seek access to the world's largest healthcare market. Almost every company sooner or later faces the question of how to approach this market. Together with our experts, we will take a concise and practical look at the challenges and trends in US business. We will explore what really matters. Come and join the discussion!
Dr. Patrik Frei
Venture Valuation AG
Bradley H. Doline
Wilson Sonsini Goodrich & Rosati
Dr. Wolf S. Richter
Pharmtrace klinische Entwicklung GmbH